Research > ETFs > ETF / ETP Commentary > 

JP Morgan Leads Top Five Active ETFs by June Flows

Active ETFs continue to thrive amid the overall ETF surge that has dominated asset management in recent years. Active ETFs not only provide adaptable, thematic opportunities. They increasingly are competing with passive funds to play a core plus or even core allocation role. June saw some particularly intriguing results, with JP Morgan having two ETFs in that top five.Key Takeaways: Active ETFs did well in the last month with some big inflows to names led by DRAM. DRAM picked up $7.5 billion plus having only launched recently. Two funds from JP Morgan made that top five for June. The top five non-leveraged or inverse active ETFs ranked by June flows starts off with the Roundhill Memory ETF (DRAM). DRAM just launched in April this year and charges a 65 basis point (bps) fee to actively invest in global memory firms. Using a proprietary process and both stocks and derivatives, the fund invests in companies active in areas like NAND flash memory, hard disk and solid-state drives, and more.  That has helped DRAM add an eye-watering $7.8 billion over the last four weeks according to ETF Database data. The fund has returned 133% in the last three months. The next-largest active ETF by June flows added just $1.4 billion. That strategy, the Principal Capital Appreciation Select ETF (LCAP ) charges a 29 bps fee to actively invest in U.S. stocks of any size, with a large cap lean. The fund looks for long term capital growth and represents a classic active ETF with its dedicated stock picking. The strategy’s $1.4 billion in flows comes with a 14.3% return over the last three months. The next largest flows for June came into the JP Morgan Ultra-Short Income ETF (JPST A). The strategy charges an 18 bps fee to invest in short-term investment grade debt while also offering that income that appeals to so many investors. The fund gathered $1.1 billion over the last month according to ETF Database data. It has produced a 4.09% 30-day SEC yield as of June 30th per JP Morgan data. The iShares Equity Factor Rotation Active ETF (DYNF A-) takes the next spot. DYNF added $950 million over the last four weeks per ETF Database data. The strategy charges 26 bps to actively invest in U.S. large and midcap stocks with a factor rotation approach. Rotating through five factors like quality and value, the fund has returned 15.5% over the last three months. See more: What Rising Structural Inflation Means for Your Bond Portfolio Rounding out the five is a second active ETF from JP Morgan. The JPMorgan Core Plus Bond ETF (JCPB ) actively invests in U.S. and non-U.S. debt for a 38 bps fee. The strategy added just under $900 million in the last four weeks. Together, those five active ETFs run the gamut from fixed income and income ETFs to broad active strategies. As active ETFs continue to rise in significance, investors can find more and more opportunities therein.  For more news, information, and analysis, visit VettaFi | ETFDB.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.